25 May 2013
Keywords: strong, ph, data, roche, hcv, drug, r1626
Article | 06 November 2006
Swiss drug major Roche says that new clinical data on its investigational hepatitis C polymerase inhibitor R1626 shows viral
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 November 2006
24 May 2013
© 2013 thepharmaletter.com